[go: up one dir, main page]

AR071953A1 - Derivados de isoindoles y composiciones farmaceuticas que los comprenden - Google Patents

Derivados de isoindoles y composiciones farmaceuticas que los comprenden

Info

Publication number
AR071953A1
AR071953A1 ARP090101935A ARP090101935A AR071953A1 AR 071953 A1 AR071953 A1 AR 071953A1 AR P090101935 A ARP090101935 A AR P090101935A AR P090101935 A ARP090101935 A AR P090101935A AR 071953 A1 AR071953 A1 AR 071953A1
Authority
AR
Argentina
Prior art keywords
alkyl
optionally substituted
fluoro
alkoxy
isoindols
Prior art date
Application number
ARP090101935A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR071953A1 publication Critical patent/AR071953A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Se reivindican compuestos de formula (1), en la que R1 es hidrogeno; alquilo C1-3, opcionalmente sustituido con uno o m s sustituyentes seleccionados independientemente de hidroxi, alcoxi C1-3 y fluoro; alcoxi C1-3, opcionalmente sustituido con uno o m s fluoro; ciano; hidroxi o halo; m es 1, 2 o 3; Het es heteroarilo C5-6 sustituido con 1 o 2 sustituyentes R2; R2 es alquilo C1-4, haloalquilo C1-4, haloalcoxi C1-4, halo; alcoxi C1-4 o cicloalquil C3-7-oxi, opcionalmente sustituido con uno o m s fluoro; D es heteroarilo C5-6 heterocicloalquilo C3-7 o cicloalquilo C3-7; en el que cada D puede estar opcionalmente sustituido con uno o m s X4; X4 es halo; o alquilo C1-3, opcionalmente sustituido con uno o m s fluoro; alquil C1-3-O-alquilo C1-3, opcionalmente sustituido con uno o m s fluoro; alcoxi C1-3, opcionalmente sustituido con uno o m s fluoro; ciano; hidroxi; oxo; R3O(C=O); o R4(C=O); R3 es alquilo alquilo C1-4; alquil C1-4-O-alquilo C1-4, cicloalquilo C5-6, arilo; o aril-alquilo C1-2; R4 es alquilo C1-4; o heteroarilo C5-6; L1 es alquileno C1-4, o un enlace; y L2 es alquileno C1-3. Los compuestos de la presente son utiles en terapia, tal como terapia contra el dolor.
ARP090101935A 2008-05-30 2009-05-29 Derivados de isoindoles y composiciones farmaceuticas que los comprenden AR071953A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5730408P 2008-05-30 2008-05-30

Publications (1)

Publication Number Publication Date
AR071953A1 true AR071953A1 (es) 2010-07-28

Family

ID=41377345

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090101935A AR071953A1 (es) 2008-05-30 2009-05-29 Derivados de isoindoles y composiciones farmaceuticas que los comprenden

Country Status (6)

Country Link
AR (1) AR071953A1 (es)
CL (1) CL2009001327A1 (es)
PE (1) PE20100146A1 (es)
TW (1) TW201000462A (es)
UY (1) UY31855A (es)
WO (1) WO2009145720A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20241195T1 (hr) 2018-09-10 2024-11-22 Kaken Pharmaceutical Co., Ltd. Novi heteroaromatski amidni derivat i lijek koji ga sadrži
JP7701162B2 (ja) * 2020-02-28 2025-07-01 科研製薬株式会社 新規ヘテロ芳香族アミド誘導体又はその塩からなる医薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200613272A (en) * 2004-08-13 2006-05-01 Astrazeneca Ab Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
TW200804281A (en) * 2006-02-16 2008-01-16 Astrazeneca Ab New metabotropic glutamate receptor-potentiating isoindolones
CN101490002A (zh) * 2006-07-12 2009-07-22 阿斯利康(瑞典)有限公司 作为止痛剂的3-氧代异二氢吲哚-1-甲酰胺衍生物
TW200812962A (en) * 2006-07-12 2008-03-16 Astrazeneca Ab New compounds I/418

Also Published As

Publication number Publication date
WO2009145720A1 (en) 2009-12-03
UY31855A (es) 2010-01-05
CL2009001327A1 (es) 2010-01-15
PE20100146A1 (es) 2010-03-21
TW201000462A (en) 2010-01-01

Similar Documents

Publication Publication Date Title
DOP2010000046A (es) Compuestos de biciclolactama sustituida
AR061548A1 (es) 3-aminopirrolidino-4-lactamas sustituidas como inhibidoras de dipeptidilpeptidasa iv (dpp-iv), composiciones farmaceuticas que las comprenden y el uso de las mismas en el tratamiento de la diabetes ii.
AR063912A1 (es) Derivados de 1,2,4 oxadiazol. composiciones farmaceuticas.
CO6180440A2 (es) Compuestos y composiciones como inhibidores de proteinquinasas
BRPI1007456A2 (pt) derivados de azaespiranil-alquilcarbamatos de compostos heterocíclicos com 5 membros, o respectivo preparo e a respectiva aplicação em terapêutica
CO6741198A2 (es) Compuestos heterocíclicos nitrogenados sustituidos fusionados en posición 6,6 y usos de los mismos
CR11245A (es) Mejoras en compuestos organicos o relacionadas con los mismos
UY32463A (es) Derivados de (1-{[5-(4-halo-2-trifluorometil-fenilamino)piridin-2-ilmetil]-carbamoil -ciclopropil)-amidas de ácidos pirimidin-carboxílicos y similares; sus enantiómeros, sus diastereoisómeros, y sus sales, fisiológicamente tolerables.
AR074782A1 (es) Antranilamidas sustituidas con tetrazol como plaguicidas
AR055635A1 (es) Uso de sulfonanilidas como herbicidas
UY30493A1 (es) Compuestos derivados 5-cloro-1??h,3h-espiro[ 1-benzofuran-2, 4??- piperidin]-1??-ilo sustituidos de los acidos acético y 2-metil- propanoico, composiciones farmacéuticas, procedimientos de preparacion y aplicaciones
AR060590A1 (es) Compuestos imidazo
CO6160295A2 (es) Derivados de benzazepina utiles como antagonistas de vasopresina
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
CO6300865A2 (es) Derivados polisustituidos de 2 aril-6-fenil-imidazo[1,2-a]piridinas su preparacion y su aplicacion en terapeutica
AR060591A1 (es) Compuestos imidazo
AR082004A1 (es) Compuestos de fusion de piridina
UY33205A (es) Naftiridinas sustituidas y su uso como medicamentos
AR060489A1 (es) Derivados del acido benzoazepin - oxi- acetico como agonistas de ppar - delta usados para aumentar hdl- c, reducir ldl-c y reducir colesterol
SV2010003485A (es) Depsipeptidos ciclicos
AR077141A1 (es) Derivados de 4-aminopicolatos sustituidos, procesos de preparacion y composiciones herbicidas que lo comprenden
PE20080427A1 (es) Agentes antivirales
CO6551705A2 (es) Derivados de 3.4.4a.10b- tetrahidro-1h-tiopirano-[4.3-c]- isoquinolina
UY29486A1 (es) Compuestos utiles en terapia
AR083861A1 (es) OXAZOLIDINONAS COMO MODULADORES DE mGluR5 Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN

Legal Events

Date Code Title Description
FB Suspension of granting procedure